Individual Treatment of Ustekinumab in Perianal Fistulizing Crohn's Disease
-
- STATUS
- Not Recruiting
-
- participants needed
- 119
-
- sponsor
- Second Affiliated Hospital of Wenzhou Medical University
Updated on 23 May 2025
Online studies
Summary
This study intends to further explore the actual efficacy of ustekinumab in the individualized treatment of anal fistula Crohn's disease.
Description
Participants in the study receive ustekinumab injections as part of routine medical care. The study just observes the efficacy retrospectively and does not interfere with treatment.
Details
| Condition | Crohn Disease |
|---|---|
| Age | 18years - 65years |
| Clinical Study Identifier | NCT06739278 |
| Sponsor | Second Affiliated Hospital of Wenzhou Medical University |
| Last Modified on | 23 May 2025 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.